Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis.
作者信息
Yang Chunxiu, Li Yueying, Xiao Shu-Yuan
机构信息
Department of Pathology, Wuhan University Zhongnan Hospital, Wuhan, China.
Department of Pathology, Wuhan University Zhongnan Hospital, Wuhan, China; Department of Pathology, University of Chicago Medicine, USA.
出版信息
EBioMedicine. 2020 Oct;60:103004. doi: 10.1016/j.ebiom.2020.103004. Epub 2020 Sep 24.
Abstract
摘要
相似文献
1
Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis.呼吸道中血管紧张素转换酶2（ACE2）的差异表达及其与新型冠状病毒肺炎（COVID-19）发病机制的关系
EBioMedicine. 2020 Oct;60:103004. doi: 10.1016/j.ebiom.2020.103004. Epub 2020 Sep 24.
2
Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.雌激素调节分化气道上皮细胞中 SARS-CoV-2 受体 ACE2 的表达。
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1280-L1281. doi: 10.1152/ajplung.00153.2020. Epub 2020 May 20.
3
Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?血管紧张素转换酶2（ACE2）的下调会导致新型冠状病毒肺炎（COVID-19）中肾素-血管紧张素系统的过度刺激：我们应该阻断肾素-血管紧张素系统吗？
Hypertens Res. 2020 Aug;43(8):854-856. doi: 10.1038/s41440-020-0476-3. Epub 2020 May 22.
4
ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.睾丸中 ACE2 受体的表达：在 2019 年冠状病毒病发病机制中的意义。
Biol Reprod. 2020 Aug 21;103(3):449-451. doi: 10.1093/biolre/ioaa080.
5
SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对血管紧张素转换酶2（ACE2）的下调作用以及血管紧张素转换酶抑制剂（ACEIs）/血管紧张素Ⅱ受体阻滞剂（ARBs）的多效性作用
Hypertens Res. 2020 Sep;43(9):985-986. doi: 10.1038/s41440-020-0488-z. Epub 2020 Jun 10.
6
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.血管紧张素转换酶2（ACE2）受体、哮喘与严重新型冠状病毒肺炎感染风险
Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3.
7
The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2（ACE2）之间的相互作用可能会对骨骼肌的病毒易感性和肌病产生影响。
J Appl Physiol (1985). 2020 Oct 1;129(4):864-867. doi: 10.1152/japplphysiol.00321.2020. Epub 2020 Jul 16.
8
Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.回复：“2019冠状病毒病背景下肾素-血管紧张素-醛固酮系统抑制剂与血管紧张素转换酶2的相互作用”
Nat Rev Cardiol. 2020 May;17(5):313-314. doi: 10.1038/s41569-020-0369-9.
9
Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission.颗粒物与 SARS-CoV-2：COVID-19 传播的一种可能模型。
Sci Total Environ. 2021 Jan 1;750:141532. doi: 10.1016/j.scitotenv.2020.141532. Epub 2020 Aug 5.
10
Reply to Letter to the Editor: "COVID-19: is the ACE2 just a foe?".致编辑的信的回复：“COVID-19：血管紧张素转换酶2只是敌人吗？”
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1031. doi: 10.1152/ajplung.00134.2020.
引用本文的文献
1
Symptom propagation in respiratory pathogens of public health concern: a review of the evidence.公共卫生关注的呼吸道病原体的症状传播：证据综述。
J R Soc Interface. 2024 Jul;21(216):20240009. doi: 10.1098/rsif.2024.0009. Epub 2024 Jul 24.
2
Preventive Measures against Pandemics from the Beginning of Civilization to Nowadays-How Everything Has Remained the Same over the Millennia.从文明起源至今的大流行预防措施——数千年来一切如何保持不变。
J Clin Med. 2022 Apr 1;11(7):1960. doi: 10.3390/jcm11071960.
3
The role of microRNAs in COVID-19 with a focus on miR-200c.微小RNA在新型冠状病毒肺炎中的作用，重点关注miR-200c
J Circ Biomark. 2022 Mar 21;11:14-23. doi: 10.33393/jcb.2022.2356. eCollection 2022 Jan-Dec.
4
Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.针对 SARS-CoV-2 感染靶向神经纤毛蛋白 1 的观点和潜在方法。
Mol Med. 2021 Dec 27;27(1):162. doi: 10.1186/s10020-021-00423-y.
5
Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking.COVID-19 中潜在刺突糖蛋白/ACE2 双靶点拮抗剂的计算机分子对接筛选。
J Virol Methods. 2022 Mar;301:114424. doi: 10.1016/j.jviromet.2021.114424. Epub 2021 Dec 10.
6
Do We Really Understand the Relationship Between Expression of ACE2 and Coronavirus Disease 2019 Lung Pathophysiology?我们真的理解血管紧张素转换酶2（ACE2）的表达与2019冠状病毒病肺部病理生理学之间的关系吗？
J Thorac Oncol. 2021 Nov;16(11):1785-1787. doi: 10.1016/j.jtho.2021.08.014.
7
Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases.患有慢性炎症性肠病的儿童和成人感染新型冠状病毒的风险、病程及影响
Children (Basel). 2021 Aug 30;8(9):753. doi: 10.3390/children8090753.
8
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.Nrf2 的好坏：癌症研究的新进展和对 COVID-19 的新视角。
Int J Mol Sci. 2021 Jul 26;22(15):7963. doi: 10.3390/ijms22157963.
9
miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity.通过细菌脂多糖和脂磷壁酸上调miR-200c-3p并下调血管紧张素转换酶2，这是新冠病毒疾病治疗和免疫方面的有趣研究点。
Mol Biol Rep. 2021 Jul;48(7):5809-5810. doi: 10.1007/s11033-021-06378-x. Epub 2021 May 3.
10
COVID-19 and inflammatory bowel disease: A pathophysiological assessment.COVID-19 与炎症性肠病：病理生理学评估。
Biomed Pharmacother. 2021 Mar;135:111233. doi: 10.1016/j.biopha.2021.111233. Epub 2021 Jan 5.
本文引用的文献
1
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.人类呼吸道中 SARS-CoV-2 受体 ACE2 的异质性表达。
EBioMedicine. 2020 Oct;60:102976. doi: 10.1016/j.ebiom.2020.102976. Epub 2020 Sep 21.
2
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.中国武汉某单一中心 402 例 COVID-19 患者的临床结局。
J Med Virol. 2020 Nov;92(11):2751-2757. doi: 10.1002/jmv.26168. Epub 2020 Jun 29.
3
Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters.新型冠状病毒肺炎患者的死亡率分析：临床和实验室参数
Open Forum Infect Dis. 2020 Apr 29;7(5):ofaa152. doi: 10.1093/ofid/ofaa152. eCollection 2020 May.
4
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
5
Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process.2019新型冠状病毒肺炎病理学：一个动态的疾病过程
J Thorac Oncol. 2020 May;15(5):e67-e68. doi: 10.1016/j.jtho.2020.03.015.
6
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入因子与固有免疫基因一起在鼻上皮细胞中高表达。
Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23.
7
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.通过尸体核心活检对 2019 年新型冠状病毒病（COVID-19）的病理学研究。
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
8
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.SARS-CoV-2 受体 ACE2 和 TMPRSS2 主要表达于支气管的瞬态分泌细胞中。
EMBO J. 2020 May 18;39(10):e105114. doi: 10.15252/embj.20105114. Epub 2020 Apr 14.
9
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
Zotero 插件